AzTrials
AzTrials

Cleft Lip and PalateCDAABGNCT04987190

Progression of Grafted Bone Density in Cleft Alveolus

An observational study of Cleft Lip and Palate, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The patients with unilateral and bilateral cleft lip and palate received alveolar bone graft surgery. Two time points of cone beam CT were taken for all the patients: post-operative 6 months, and post-operative 2 years. All the CT images were reviewed for the analysis of grafted bone density. Read more about this study

Who is it for?
Ages 8 to 10 years
Conditions the study is for
Cleft Lip and Palate
What is being tested?
alveolar bone graft
Type of treatment
Surgery or procedure
How many people
40 participants
Where
1 siteTaiwan
Study dates
25 Jan 2021to 4 Jul 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 10 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: In total, 40 patients, who had an average age of 9.45 ± 1.61 years when they received ABG, were enrolled.

Who may be able to join

  • Patients who had nonsyndromic unilateral or bilateral cleft lip and alveolus with or without cleft palate
  • Patients received alveolar bone graft at their 9 years of age
  • Patients received twice CBCT after the surgery

Who cannot join

  • Patient had syndromic cleft alveolus
  • Patient underwent two-stage ABG (performed for bilateral cases)
  • Patient exhibited failed grafted tissue

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Chang Gung Memorial Hospital

    Taoyuan

Other trials in Taiwan

About this study

Official title: Progressive Comparison of Density Assessment of Alveolar Bone Graft in Patients With Unilateral and Bilateral Cleft

The patients with unilateral and bilateral cleft lip and palate received alveolar bone graft surgery. Two time points of cone beam CT were taken for all the patients: post-operative 6 months, and post-operative 2 years. All the CT images were reviewed for the analysis of grafted bone density.

Read the detailed description

Patient Information and Data Collection Patients who had nonsyndromic unilateral or bilateral cleft lip and alveolus with or without cleft palate and received ABG at our center between 2016 and 2018 were enrolled. All patients underwent at least 2 CBCT scans after operation. Postoperative image acquisition was performed at two time points, namely 6 months (T1) and 2 years (T2) after ABG. The ABG procedures for all patients were performed by the same senior surgeon per the protocol of our center, which comprises an iliac cancellous bone graft and the sealing of the Scarpa fascia to the defect before the bone graft is packed.2,12 Patient who had syndromic cleft alveolus, who underwent two-stage ABG (performed for bilateral cases), or who exhibited failed grafted tissue were excluded. In total, 40 patients were enrolled in the present study. The demographic and clinical variables for ABG were retrospectively collected through a review of medical charts. All CBCT images were obtained using an i-CAT CBCT scanner (Imaging Sciences International, Hatfield, PA, USA); the parameters for the images are as follows: 120 kVp, voxel size of 0.4 × 0.4 × 0.4 mm3, 40-s scan time, and 22 × 16-cm field of view.

BMD Measurement The Picture Archiving and Communication System (PACS) was applied for image analysis. In addition, areas of interest were checked in the axial view slice by slice to locate the grafted tissue. Three methods (A, B, and C), which differed by the size of the selected area, were designed to measure Hounsfield units (HU). For all methods, we first identified the most superior and inferior planes transecting the grafted tissue. Subsequently, the middle plane of the grafted tissue was identified. For the selected plane, the distance between two teeth had to be larger than 2.5 mm in diameter; this was required for all three methods. On each plane, the selected circular area is defined as being located at the midpoint of the line between the centers of the two adjacent teeth. The HU of the selected area could be obtained using PACS.

For Method A, the circular zone located 1 mm from the adjacent teeth was selected. For Method B, the largest circular zone that exactly transected the two adjacent teeth or was tangent to the surrounding cortical bone was selected. For Method C, a circle was drawn with a diameter of 2 mm. Furthermore, an area of 2 × 0.5 mm2 in the pogonion was selected to obtain its HU at T1 and T2; this was the reference for calibration (Figure, Supplemental Digital Content 1). HU was the reference for BMD13 and represented the average density of the three planes. Calibrated BMD (BMDc, %) was defined using the following formula:

〖BMD〗_c (%)=〖HU〗_(selected zone)/〖HU〗_pogonion ×100.

Density enhancement rate (%) was calculated using the following formula:

Density enhancing rate (%)= (〖BMD〗_cT2-〖BMD〗_cT1)/〖BMD〗_cT1 ×100, where BMDcT2 is BMDc measured at T2, and BMDcT1 is the BMDc at T1. All the BMD and pogonion density data were measured by one examiner and repeated twice on different dates that were separated by a 3-month interval; the second round of measurements was conducted without reference to the first-round measurements. The average of the six sets of data (two measurements for each of the three planes) was used for the final statistical analysis.

Statistical Analysis In the descriptive analysis, continuous variables were summarized by means ± standard deviations. All variables were examined for normal distribution using the Shapiro-Wilk test. Student's t-test was performed to compare the means of continuous variables with normal distribution, and a chi-squared test or Fisher's exact test was used for categorical data. Furthermore, we performed analysis of variance with repeated measures to compare the differences between the three methods with respect to BMDc measurements and density enhancement rates in normally distributed data; for data that were not normally distributed, Friedman test was used. To compare the differences in BMDc at T1 and T2, we performed a paired t-test and a Wilcoxon signed-rank test for bilateral cleft due to small sample size. Bland-Altman plots were used to evaluate the agreement of each method. Intrarater reliability for the three methods was calculated using intraclass correlation coefficients (ICCs). All statistical tests were two-tailed, and a p value less than 0.05 was considered statistically significant. All data were analyzed using SPSS 24.0 (SPSS, Chicago, IL, USA).

Being tested
alveolar bone graft
Keywords
alveolar bone grafting, alveolar cleft, bone mineral density, density enhancement rate, cone beam computed tomography (CBCT)
Medical subject headings
Cleft Lip

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • alveolar bone graftProcedure or surgery

    alveolar bone graft with Scarpa fascia done when patients were at 9 year of age

Study groups in NCT04987190
Study groupRoleWhat they receive
all cleft patients divided into unilateral and bilateral groupsOne group of cleft patients received the alveolar bone graft surgery
Receives: Procedure: alveolar bone graft

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. mean calibrated bone mineral density (BMD/pogonion density, BMDc)

    BMD presented from CBCT

    Measured: 1st BMD at post-operative 6 months

  2. mean calibrated bone mineral density (BMD/pogonion density, BMDc)

    BMD presented from CBCT

    Measured: 2nd BMD at post-operative 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2021
  2. Study start25 Jan 2021
  3. Primary completion2 Jun 2021
  4. Study completion4 Jul 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04987190
Sponsor's protocol ID
201600968A3
Acronym
CDAABG
Status last verified
Aug 2021
First submitted
22 Jul 2021
Last updated
6 Aug 2021
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Cleft Lip and Palate, run by Chang Gung Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Aug 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

mean calibrated bone mineral density (BMD/pogonion density, BMDc) (time frame: 1st BMD at post-operative 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Aug 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in